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DOI: http://dx.doi.org/10.1016/j.hemonc.2014.06.005Anaplastic large cell lymphoma (ALCL) is a T cell lymphoma occurring commonly in childhood and rarely
in adults. Central nervous system involvement in ALCL is very rare and cerebellar involvement at presen-
tation has never been described. We examine the case of a young adult who presented with a cerebellar
mass. A 19-year-old boy presented with signs of raised intracranial tension, which, on imaging, revealed a
right cerebellar mass. He underwent suboccipital craniotomy and partial excision of the tumor. However,
the histopathology was inconclusive. He subsequently presented with cerebellar signs and repeat imaging
showed recurrence of the cerebellar lesion. He underwent decompression and ventriculoperitoneal (VP)
shunting. Histopathology was suggestive of ALK (anaplastic lymphoma kinase) positive anaplastic large
cell lymphoma. The patient was started on chemotherapy. However, his neurological status deteriorated,
his condition worsened, and he expired a month later.
KEYWORDS: ALCL; Cerebellum; Brain; NHLINTRODUCTIONAnaplastic large cell lymphoma (ALCL) is a Tcell lymphoma accounting for 2–8% of allnon-Hodgkin’s lymphoma and 20–30% of
childhood lymphomas.1 Although ALCL is primarily
a nodal disease, extranodal involvement is not uncom-
mon and usually involves skin, bone, soft tissue, lung,
and liver. Central nervous system involvement in
ALCL is very rare and cerebellar involvement at pre-
sentation has never been described before. We exam-
ine the case of a young adult who presented with a
cerebellar mass.CASE REPORT
A 19-year-old boy was evaluated in a neurosurgery
center for headache and vomiting. A computerized
tomogram (CT) scan of his brain showed a focal,
mildly enhancing hypodense lesion measuring2–1 · 1.3 · 1.5 cm in the right cerebellar hemisphere
close to the midline abutting the falx cerebellum
(Figs. 1A & B). Magnetic resonance Imaging (MRI)
showed a 2.9 · 2.2 cm well-deﬁned right cerebellar
lesion, hypointense on T1 and hyperintense on T2
weighted images showing contrast enhancement
below the tentorium with obstructive hydrocephalus
(Figs. 2A–E). He underwent suboccipital craniotomy
and partial excision of the tumor. The histopathology
did not reveal any neoplastic tissue and the patient
was kept on follow-up. He was apparently asymptom-
atic for about nine months after which he developed
repeated episodes of bifrontal headache associated
with vomiting. He had unsteadiness of gait which
gradually increased, and he was unable to walk. There
was no history of loss of consciousness, seizures,
visual disturbances, weakness of limbs, bladder or
bowel disturbance. He gave history of diminished
vision in right eye since early childhood. On examina-
tion, he was conscious with normal higher mental157
Figure 1A. CT brain plain axial image showing hyperdense lesion in the
right cerebellum with surrounding edema.
Figure 1B. CT Brain post contrast axial view showing the lesion in right
cerebellar hemisphere.
Figure 2A. MRI T1 sagittal view showing hypo intense lesion with
surrounding edema in the cerebellum.
Figure 2B. MRI T1 post contrast sagittal view shows the same lesion
with intense contrast enhancement.
158
case report ANAPLASTIC LARGE CELL LYMPHOMAfunctions. Pupils were equal and reactive, and extra-
ocular movements were normal. Visual acuity was less
on the right side. Nystagmus was present on the right
side, and ﬁnger nose test was impaired on both sides.
Fundi showed early papilledema. No other cranialnerve defects were present. Motor power was grade
4+ in all four limbs. CT brain showed recurrence of
the right cerebellar lesion with surrounding edema
and obstructive hydrocephalus. He underwent
decompression and ventriculoperitoneal (VP) shunt-
ing. Post-operatively, the patient’s condition deterio-
rated; he was ventilated, and he developed
meningitis, which was managed with antibiotics.Hematol Oncol Stem Cell Ther 7(4) Fourth Quarter 2014
Figure 2C. MRI T2 weighted image sagittal view shows iso- to
hyperintense lesion with surrounding edema.
Figure 2D. MRI T1-contrat image axial view shows intense
enhancement.
Figure 2E. MRI T2 axial image shows iso- to hyperintense lesion with
surrounding edema.
Figure 3. H&E · 400 showing sheets of pleomorphic tumor cells with
classical doughnut cells.
ANAPLASTIC LARGE CELL LYMPHOMA case reportHistopathology was suggestive of malignant lym-
phoma, and he was referred to us subsequently.
The patient’s general condition was very poor. His
hemoglobin was 12.5 gm%, total WBC 8900/mm3,
and platelet 352000/mm3. His renal and liver func-
tions were unremarkable and LDH was 1352. Ultra-
sonogram of abdomen showed very small, discrete,
well-deﬁned hypoechoic lesions in the para-aortic
region. Bone marrow biopsy was normal. Histopa-
thology was diagnostic of anaplastic large cell lym-
phoma (Fig. 3) which was positive for LCA,Hematol Oncol Stem Cell Ther 7(4) Fourth Quarter 2014anaplastic lymphoma kinase (ALK) and CD30 (Figs. 4
& 5), and negative for CD5 and CD20 (Figs. 6 & 7).
Skeletal survey and bone scan were normal. He was
started on BFM90 ALCL protocol. He developed
renal failure as part of tumor lysis syndrome, and he
was subjected to hemodialysis. However, his neuro-
logical status deteriorated, his condition worsened,
and he expired a month later.DISCUSSION
ALCL, ﬁrst described in 1985, represents a distinct
category of large cell lymphoma deﬁned by the strong
expression of the cytokine receptor CD30 on all159
Figure 4. ALK · 400 Tumor cells are ALK positive.
Figure 5. CD30 · 400 Tumor cells are CD30 positive.
Figure 6. CD5 · 400 Tumor cells are negative for CD5.
Figure 7. CD20 · 400 Tumor cells are negative for CD20.
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case report ANAPLASTIC LARGE CELL LYMPHOMAneoplastic cells. ALK-positive ALCL is associated
with a chromosomal abnormality, the t(2:5)
(p23:q35) that fuses part of the nucleophosmin
(NPM) gene on chromosome 5q35 to a portion ofthe ALK receptor tyrosine kinase gene on chromo-
some 2p23, resulting in expression of a chimeric
NPM-ALK protein.2 ALK+ ALCL is more com-
monly seen.
There are two forms of primary ALCLs: a primary
systemic and primary cutaneous form. ALCL positive
for the ALK protein frequently involves both lymph
nodes and extranodal sites, which commonly include
skin (21%), bone (17%), soft tissues (17%), lung
(11%) and liver (8%) while involvement of the gut
and central nervous system (CNS) is rare.3
Ponzoni reported the ﬁrst case of primary brain
CD30+, ALK+ ALCL with T cell phenotype in a
29-year-old male.4 A 31-year-old male with ALK+
ALCL of leptomeninges, who was treated with high
dose methotrexate and intrathecal chemotherapy,
has also been described.5 A 20-year-old male with pri-
mary central nervous system lymphoma (PCNS)
ALCL was treated with chemotherapy and radiation,
and survived for eight years.6
Cerebellar involvement in ALCL is very rare and
has been described in only one patient, a 19-year-
old female during the course of her treatment.7 A cer-
ebellar mass as a presenting manifestation of ALCL
has never been described before and this is the ﬁrst
such case to be reported in the global medical litera-
ture. The most important prognostic factor in ALCL
is ALK positivity, which is associated with a good
prognosis. The overall ﬁve-year survival in ALK+
patients is 70% versus 49% in ALK cases.8 Unfortu-
nately, our patient died soon after starting
chemotherapy.DISCLOSURE
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